What can we learn from the 2025 expenses and income report?
Article L. 111-11 of the French Social Security Code stipulates that the Union nationale des caisses d'assurance maladie (French National Union…
Requesting a price that is “too high” may justify the refusal of reimbursement… without negotiation!
The French Social Security Code allows ministers to refuse the reimbursement of a healthcare product if it is likely to…
Pharma package: pharmaceutical companies soon to be required to apply for medicinal product reimbursement?
The European Parliament has just adopted in first reading the "pharmaceutical package" which includes a new directive and a new…
Product paybacks: pricing agreements must be strictly interpreted (annulment of a CEPS decision)
The French Economic Committee for Health Products (CEPS) can negotiate or set paybacks on products reimbursed by the French health…
CEPS report: what the 2022 report says about delays and disputes
On January 23, 2024, the French Economic Committee for Health Products (“CEPS”) published its activity report for 2022. It describes…
Price/volume paybacks and reimbursable indications: a review of the judge’s recent rulings
As a reminder, with the aim of regulating health insurance expenditures, paybacks may be negotiated between the French Economic Committee…